Search

Your search keyword '"D V Goryachev"' showing total 36 results

Search Constraints

Start Over You searched for: Author "D V Goryachev" Remove constraint Author: "D V Goryachev" Topic medicine Remove constraint Topic: medicine
36 results on '"D V Goryachev"'

Search Results

1. Changes in inflammatory activity of rheumatoid arthritis at early stages of basic therapy with leflunomide

2. Markov's model of decision making on basic therapy of rheumatoid arthritis: monotherapy and its cost

Catalog

Books, media, physical & digital resources

3. Planning a Clinical Trial Programme for Medicinal Products for the Treatment of Axial Spondyloarthritis

4. Recommendations on the Clinical Trial Programme for Diabetes Medicines

5. Planning and Evaluation of Bioequivalence Studies of Drugs with Nonlinear Pharmacokinetics

6. Planning a Clinical Development Programme for Medicines for Bronchial Asthma

7. Current Approaches to Planning and Conducting Clinical Trials of Medicinal Products for the Treatment of Crohn's Disease

8. Planning and Evaluation of Bioequivalence Studies of Lopinavir/Ritonavir Preparations

9. Expert Approaches to the Assessment of Losartan Drugs Bioequivalence

10. Quality Standards of Preclinical Pharmacological Studies

11. Investigation Planning and Bioequivalence evaluation of Angiotensin II Receptor Antagonists

12. Evaluation of Bioequivalence of Generic Imatinib Products and Generic Tacrolimus Products Based on Indirect Comparison of the Results of Their Bioequivalence Studies

13. Development of an Approach to the Assessment of Changes to Approved Biological Products

14. Criteria for Assessment of Cognitive Impairment in Clinical Trials

15. PLANNING AND EVALUATION OF BIOEQUIVALENCE STUDIES OF ATAZANAVIR PRODUCTS

16. Planning of a Clinical Data Registry for Basic Anti-Inflammatory Drugs for the Treatment of Rheumatoid Arthritis

17. Planning and Assessment of Bioequivalence Studies of Darunavir Preparations

18. INFLUENCE OF SEX DIFFERENCES ON PHARMACOKINETICS OF DRUGS WITHIN THE FRAMEWORK OF BIOEQUIVALENCE STUDIES OF GENERIC MEDICINAL PRODUCTS

19. PRECLINICAL AND CLINICAL ASPECTS OF THE DEVELOPMENT OF BIOMEDICAL CELL PRODUCTS

20. Fecal microbiota transplantation: therapeutical approaches and regulatory framework

21. THE EFFICACY AND SAFETY OF CARMOLIS GEL IN THE COMBINATION THERAPY OF KNEE OSTEOARTHRITIS: RESULTS OF A MULTICENTER CLINICAL TRIAL

22. Influence of Human Biorhythms on the Blood Glucose Level and the Efficacy of Hypoglycemic Drugs (Review)

23. EVALUATION OF A DECRESE IN WORK PRODUCTIVITY IN PATIENTS WITH RHEUMATOID ARTHRITIS

24. Specific Anti-IIa Activity is a Key Indicator of Safety and Efficacy in Validation of Biosimilarity of Unfractioned Heparin Preparations

25. Relationship of the clinical characteristics of rheumatoid arthritis to work capacity and efficiency

26. Russian registry of Infliximab.Impact of therapy on the functional status of patients with rheumatoid arthritis

27. EVALUATION OF THE FUNCTIONAL STATUS OF THE RUSSIAN POPULATION OF PATIENTSWITH RHEUMATOID ARTHRITIS ACCORDING THE DATA OF THE RAiSeR STUDY

28. RHEUMATOID ARTHRITIS IN RHEUMATOLOGICAL CARE OF RUSSIA: THE SEVERITY OF THE DISEASE IN A RUSSIAN PATIENT POPULATION: A CROSS-SECTIONAL EPIDEMIOLOGICAL STUDY (RAISER)

29. Influence of disease activity and treatment on rate of joint destruction in rheumatoid arthritis

30. SF-36 questionnaire population quality of life indices Objective

31. THE EFFICACY AND SAFETY OF IMMARD (HYDROXYCHLOROQUINE) IN RHEUMATOID ARTHRITIS ACCORDING TO THE DATA OF AN OPEN-LABEL UNCONTROLLED TRIAL IN OUTPATIENT PRACTICE

32. Efficiency and safety of leflunomide in rheumatoid arthritis: Results of a Russian observational multicenter of trial

33. Pharmacoeconomic analysis of using biological agents in the treatment of rheumatoid arthritis

34. SHOULD DISEASE-MODIFYING THERAPY BE STOPPED IN PATIENTS WITH RHEUMATOID ARTHRITIS BEFORE ENDOPROSTHETIC JOINT REPLACEMENT?

36. Lethality of patients with rheumatoid arthritis depending on adalimumab administration: imitation modeling